Cross-sectional analysis of national testosterone prescribing through prescription drug monitoring programs, 2018-2022.

ABSTRACT:

Background

For two decades preceding the COVID-19 pandemic, testosterone therapy (TT) became more prevalent in the US. Given the forced shift in practice patterns and healthcare accessibility during the pandemic, it was unclear how TT utilization would change.

Objective

To assess the change in testosterone prescriptions nationally.

Design

Cross-sectional study.

Data sources

State prescription drug monitoring program data between 2018 and 2022.

Participants

All individuals filling testosterone prescriptions in participating states.

Measurements

Unique people filling testosterone prescriptions annually, demographic information on gender and age as available.

Results

In 2022 there was a 27% relative increase of subjects treated with TT (+439,6

SUBMITTER: Selinger S 

PROVIDER: S-EPMC11355536 | biostudies-literature | 2024

REPOSITORIES: biostudies-literature